ACCARDI, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 431
EU - Europa 390
AS - Asia 203
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 1.042
Nazione #
US - Stati Uniti d'America 416
SE - Svezia 134
CN - Cina 109
IE - Irlanda 80
SG - Singapore 63
IT - Italia 54
DE - Germania 27
TR - Turchia 27
FR - Francia 21
CA - Canada 15
CI - Costa d'Avorio 14
RO - Romania 13
FI - Finlandia 10
AT - Austria 9
GB - Regno Unito 9
BE - Belgio 8
CZ - Repubblica Ceca 8
ES - Italia 4
UA - Ucraina 3
BG - Bulgaria 2
BR - Brasile 2
EU - Europa 2
IN - India 2
NL - Olanda 2
BY - Bielorussia 1
IR - Iran 1
LT - Lituania 1
LU - Lussemburgo 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 1.042
Città #
Chandler 110
Dublin 80
Singapore 48
Ashburn 39
Ann Arbor 34
Izmir 24
Shanghai 23
Boardman 21
Dearborn 21
New York 20
Parma 16
Nanjing 15
Abidjan 14
Toronto 14
Focsani 13
Marseille 13
Munich 13
Princeton 13
Beijing 11
Helsinki 10
Vienna 9
Brussels 8
Hebei 8
Bremen 7
Shenyang 7
Brno 6
Los Angeles 6
Romainville 6
Milan 5
Rho 5
Wilmington 5
Hefei 4
Kunming 4
Madrid 4
Nanchang 4
San Mateo 4
Changsha 3
Des Moines 3
Guangzhou 3
Jinan 3
Kocaeli 3
Norwalk 3
Rome 3
Tianjin 3
Woodbridge 3
Zhengzhou 3
Dallas 2
Deiva Marina 2
Florence 2
Jacksonville 2
Jiaxing 2
London 2
Modena 2
Redwood City 2
Seattle 2
Torino 2
Waltham 2
Amsterdam 1
Aosta 1
Belgrade 1
Borås 1
Buffalo 1
Chengdu 1
Edinburgh 1
Fremont 1
Haikou 1
Harbin 1
Houston 1
Huizen 1
Luxembourg 1
Matera 1
Miami 1
Mountain View 1
Orange 1
Oslo 1
Ottawa 1
Ourilândia do Norte Municipality 1
Paris 1
Radomir 1
Sabz 1
Salvador 1
San Francisco 1
Sofia 1
Somerville 1
Velletri 1
Vitebsk 1
Volgograd 1
Walnut 1
Xian 1
Totale 728
Nome #
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 102
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 102
The Proteasome and Myeloma-Associated Bone Disease 94
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 88
Novel targets for the treatment of relapsing multiple myeloma 88
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 87
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 76
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 75
Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma 71
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 71
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 69
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma 67
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 60
CD38 expression by plasma cells in extramedullary multiple myeloma 24
Totale 1.074
Categoria #
all - tutte 4.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202076 0 0 0 0 6 25 12 2 14 12 1 4
2020/202162 2 1 6 1 21 4 2 2 11 4 3 5
2021/2022107 1 4 3 22 0 2 17 5 4 3 16 30
2022/2023395 58 54 19 29 46 29 23 16 96 4 16 5
2023/2024147 3 11 3 4 16 46 7 9 1 7 10 30
2024/2025151 17 18 28 59 29 0 0 0 0 0 0 0
Totale 1.074